Author

Tenley Schwarz

Institution: Swedish Medical Center

Observed institution: Swedish Medical Center

OpenAlex ID: A5111225744

Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab

2025 · Taylor R. Brooks, Emily C. Zabor, et al. · Blood · 41

Outcomes following disease progression after epcoritamab or glofitamab in the real-world outcomes of bispecific T-cell engagers (REALBiTE) multi-center, retrospective cohort study

2025 · Taylor Brooks, Agrima Mian, et al. · Blood · 1

Risk factors for cytokine release syndrome and neurotoxicity in patients receiving epcoritamab or glofitamab for large B cell lymphoma: A multi-center, retrospective, real world analysis.

2025 · XI Yang, Yasmin Karimi, et al. · Blood · 1

Evaluation of the toxicity and outcomes of the combination of midostaurin and CLAG-M in patients with FLT3-mutated acute myeloid leukemia (AML): A multi-center retrospective analysis.

2024 · Ashley Wen Chen, Grace Tonghwa Baek, et al. · Journal of Clinical Oncology · 1

Safety and efficacy of the use of anabolic bone agents in patients with underlying plasma cell dyscrasias: A case series.

2025 · Swathi Namburi, Tenley Schwarz, et al. · Blood

Evaluation of the Toxicity and Outcomes of the Combination of Midostaurin and CLAG-M in Patients With FLT3-Mutated Acute Myeloid Leukemia (AML): A Multicenter Retrospective Analysis

2025 · Ashley Chen, Grace Baek, et al. · Annals of Pharmacotherapy

Works count: 6

Citation count: 44

H-index: 1

I10-index: 1